Francesca Bruce (@ScripFrancesca) profile picture

I am a senior writer at the Pink Sheet, all views expressed are my own.

Joined April 2010
Francesca Bruce retweeted
German HTA: Clinical Cancer Registries Could Hold Key To Better Comparative Data For Benefit Assessments bit.ly/3PlbCx6 #PinkSheet
1
244
Lots of interesting sessions today at the DIA Europe 2022 meeting today, looking forward to more tomorrow. @DrugInfoAssn
Francesca Bruce retweeted
Take a look at our free-to-view @PharmaPinkSheet report by @ScripFrancesca on the finer points behind the @EMA_News review of @VertexPharma's cystic fibrosis combo Kaftrio. https://teapawt.org/t.co/uOfo7QNRYY
1
1
See why investors are concerned about big prices for advanced therapies https://teapawt.org/t.co/tZFm2kPjOw
BC province says it's leading Canada by promoting widespread biosimilar use. Re @JanssenGlobal's Remicade, @PharmaPinkSheet reports 5-10% use rate of biosimilar #infliximab in Canada after 4 years on market vs Norway (98%), UK (90%) & Scotland (85%). $$ https://teapawt.org/t.co/ePPFSIJxZt
Francesca Bruce retweeted
First application from a drug company for joint health economic assessment under new Swedish/Finnish/Norwegian pilot FINOSE expected soon, says TLV’s Niklas Hedberg #TOPRASym18
4
3
Francesca Bruce retweeted
EU parliamentary negotiations step up on controversial new regulation for member states to cooperate on HTA. Next vote scheduled for Oct 3. DG SANTE’s Flora Giorgio tells #TOPRASym18 she hopes the text will be finalised during this or the next parliament
6
1
Europe's CMDh chair Laura Oliveira Santamaria urges industry to tell us the problems you face in meeting the Brexit deadline so we can find flexible solutions to avoid drug shortages #DIAEurope2018
8
5
EMA tells me there's been a big response to its survey from companies on how they are preparing for Brexit. It has info on 90% of drugs subject to the survey; results will be published soon #DIAEurope2018
8
7
Interesting session on experience with and lessons learned from EMA's 0070 clinical data publication more than one year after the transparency initiative went live #DIAEurope2018
3
3
We need to mitigate medicines #shortages before they happen. Now we're managing them when they happen. That's too late. Maggie Dolan of NHS Commercial Solutions at #RAC18.
2017 was very distressing year in UK in terms of #shortages of generic medicines. "Never seen anything like it," says Maggie Dolan of NHS Commercial Solutions at #RAC18.
Getting senior @NICEcomms official on board @ABPI_UK is a major deal for the UK trade association. There's not a lot Carole Longson doesn't know about #HTA. #pharma teapawt.org/ABPI_UK/status/9565000…
"The appointment of Carole Longson to this new post signals our commitment to strengthening our focus on science, research and discovery in the UK" says #ABPI's chief executive Mike Thompson abpi.org.uk/media-centre/new…
4
1
Brazil's IP system could get more challenging for pharma companies https://teapawt.org/t.co/xcOTahP4Il
2
2
Francesca Bruce retweeted
Minister Ananth Kumar says India will persuade docs to follow generic prescription rule and also propagate it
2
1
Francesca Bruce retweeted
Adaptive Pathways: A Solution For Worried #Payers in Europe 🔓 ➡ https://teapawt.org/t.co/ccnbg7ZjdF via @ScripRegNeena
The #ScripAwards is free to enter and open to any research-based #pharmaceutical or #biotech company. scripawards.com
3
2
Advances in digital healthcare and a new law could make Brazil a better place to do clinical research https://teapawt.org/t.co/ghSCMPMtC9
UK passes new legislation to curb excessive drug pricing https://teapawt.org/t.co/SaSISnRtQG